EurekAlert! -
26 Mar 2020 06:00
(University of Colorado Anschutz Medical Campus) Study shows CPT1A may help ovarian cancer cells spread, also resist chemo. Group moves toward clinical trial of CPT1A inhibitor, etomoxir, in chemo-resistant ovarian cancer.
Share this Article
Comment on this Article
Please to comment